At the Board of Directors meeting held on January 26, 2026, director candidates and auditor candidates to be submitted to the 44th Annual General Meeting of Shareholders were determined. Mr. Masahiro Nakamura is scheduled to be appointed as a new auditor.
Sugi Holdings Co., Ltd. will change its executive officer structure effective March 1, 2026, appointing multiple executive officers including three new members.
For December 2025, Sugi Pharmacy existing store sales increased by 0.7% YoY; total store sales increased by 2.3%. The drugstore segment’s existing store sales declined 2.5%, while the dispensing pharmacy segment grew 9.7%. In December, 9 new stores opened, 3 stores closed, bringing the total store count to 2,309.
For the third quarter of the fiscal year ending February 2026, net sales totaled 750.127 billion yen (18.2% YoY increase), operating income was 34.137 billion yen (18.7% YoY increase), and net income attributable to owners of parent was 35.667 billion yen (87.1% YoY increase).